Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 1760 for

Edit search filters
  1. A Study Of Tucatinib Plus Trastuzumab Deruxtecan In HER2+ Breast Cancer

    Rochester, MN

  2. A Study to Assess AC220 Given in Combination with Induction and Consolidation Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  3. Rifaximin For The Treatment Of Gastrointestinal Toxicities Related To Pertuzumab-Based Therapy In Patients With Stage I-III HER2 Positive Breast Cancer

    Jacksonville, FL

  4. A Trial To Find And Investigate A Safe Dose Of BI 836858 In Combination With Decitabine For Patients With Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  5. A Study To Evaluate Gevokizumab With Standard Of Care Anti-cancer Therapies For Metastatic Colorectal, Gastroesophageal, And Renal Cancers

    Scottsdale/Phoenix, AZ

  6. A Study To Evaluate MM-151, Nal-IRI, 5-FU, And Leucovorin For RAS/RAF Wild-Type Metastatic Colorectal Cancer

    Jacksonville, FL

  7. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, And Rucaparib In Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, Or Biliary Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study Of Voruciclib Alone Or In Combination With Venetoclax In Subjects With B-Cell Malignancies Or AML

    Rochester, MN

  9. Study Of Magrolimab Combination Therapy To Treat Unresectable, Locally Advanced Or Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Safety And Preliminary Efficacy Of OBT076 In Recurrent/​Metastatic CD205+ Solid Tumors

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer